Mattiucci, Gian Carlo
 Distribuzione geografica
Continente #
NA - Nord America 6.685
EU - Europa 5.378
AS - Asia 4.859
SA - Sud America 906
AF - Africa 138
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 14
Totale 17.998
Nazione #
US - Stati Uniti d'America 6.533
SG - Singapore 2.277
DE - Germania 1.975
CN - Cina 1.083
SE - Svezia 995
BR - Brasile 743
IT - Italia 509
FR - Francia 472
VN - Vietnam 458
UA - Ucraina 337
IN - India 265
GB - Regno Unito 240
IE - Irlanda 224
ID - Indonesia 158
FI - Finlandia 148
RU - Federazione Russa 104
JP - Giappone 103
TR - Turchia 97
PL - Polonia 87
HK - Hong Kong 71
CA - Canada 70
AR - Argentina 66
BE - Belgio 62
BD - Bangladesh 59
IQ - Iraq 57
MX - Messico 47
NL - Olanda 47
CZ - Repubblica Ceca 39
ZA - Sudafrica 36
CI - Costa d'Avorio 34
IR - Iran 31
AT - Austria 27
SA - Arabia Saudita 27
EC - Ecuador 26
ES - Italia 24
PK - Pakistan 23
CO - Colombia 17
AU - Australia 15
MA - Marocco 14
PH - Filippine 14
TN - Tunisia 14
UZ - Uzbekistan 14
VE - Venezuela 13
AZ - Azerbaigian 12
CH - Svizzera 12
KR - Corea 12
UY - Uruguay 12
JO - Giordania 11
LT - Lituania 11
CL - Cile 10
KE - Kenya 10
EU - Europa 9
RO - Romania 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
IL - Israele 8
JM - Giamaica 8
KZ - Kazakistan 8
NO - Norvegia 7
NP - Nepal 7
PS - Palestinian Territory 7
BO - Bolivia 6
LK - Sri Lanka 6
LU - Lussemburgo 6
PE - Perù 6
PT - Portogallo 6
PY - Paraguay 6
AL - Albania 5
AM - Armenia 5
DK - Danimarca 5
GR - Grecia 5
OM - Oman 5
RS - Serbia 5
SN - Senegal 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
ET - Etiopia 4
KG - Kirghizistan 4
KW - Kuwait 4
MY - Malesia 4
NG - Nigeria 4
NI - Nicaragua 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
LB - Libano 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
BY - Bielorussia 2
BZ - Belize 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MN - Mongolia 2
PR - Porto Rico 2
Totale 17.973
Città #
Singapore 1.239
Chandler 1.081
Ashburn 650
San Jose 503
Beijing 233
Jacksonville 227
Dublin 224
Ann Arbor 216
New York 205
San Mateo 202
The Dalles 196
Los Angeles 154
Ho Chi Minh City 151
Dearborn 145
Nanjing 137
Jakarta 134
Lauterbourg 132
Wilmington 131
Munich 122
Woodbridge 117
Boston 115
Hanoi 107
Milan 106
Frankfurt am Main 97
Nürnberg 92
Tokyo 91
Marseille 73
Warsaw 72
São Paulo 70
Princeton 69
Bremen 67
Hong Kong 67
Izmir 65
Hefei 62
Brussels 61
Fairfield 60
Hyderabad 60
Cattolica 59
Dallas 57
Rome 56
Lawrence 55
Houston 54
Moscow 52
Helsinki 50
Seattle 49
Nanchang 45
Council Bluffs 43
Redwood City 43
Buffalo 40
London 35
Abidjan 34
Santa Clara 33
Zhengzhou 33
Detroit 30
Chicago 29
Shenyang 29
Boardman 28
Kunming 28
Redmond 28
Jiaxing 27
Leawood 27
Da Nang 26
Paris 26
St Louis 26
Nuremberg 25
Johannesburg 24
Orem 24
Amsterdam 23
Augusta 23
Brooklyn 23
Cambridge 23
Shanghai 23
Norwalk 21
Tianjin 21
Changsha 20
Turku 20
Pune 19
Toronto 19
Haiphong 18
Hebei 18
Kent 18
Stockholm 18
Atlanta 17
Belo Horizonte 17
Curitiba 17
Ottawa 17
Chennai 16
Düsseldorf 16
Rio de Janeiro 16
Baghdad 15
Guangzhou 15
Montreal 15
Phoenix 15
Poplar 15
Brasília 14
Hangzhou 14
Mexico City 14
Baku 12
North Bergen 12
University Park 12
Totale 9.224
Nome #
EP-1181: Prostheses irradiation in breast cancer: clinical and aesthetic outcomes in retrospective series 264
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 231
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 226
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 220
Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark? 219
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 215
Reducing heart dose during left breast cancer radiotherapy: comparison among 3 radiation techniques 213
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 197
Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term Analysis 196
A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer 195
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 191
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 191
The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center 190
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 188
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 187
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 187
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 185
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 182
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 181
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 180
Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed system 179
Patients’ Satisfaction by SmileInTM Totems in Radiotherapy: A Two-Year Mono-Institutional Experience 178
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 174
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 173
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 173
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 173
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 170
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 167
Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience 166
Reducing heart dose during left breast cancer radiotherapy: Comparison among 3 radiation techniques 166
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 164
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 163
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 162
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 160
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 159
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 159
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 156
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 156
Functional results of exclusive interventional radiotherapy (brachytherapy) in the treatment of nasal vestibule carcinomas 155
Low-dose hyperradiosensitivity: is there a place for future investigation in clinical settings? 154
Survival after radiotherapy in gastric cancer: systematic review and meta-analysis. 153
Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer 153
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 151
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 151
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 151
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 150
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 149
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 148
Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach 148
Recurrence in region of spared parotid gland in patient receiving definitive intensity-modulated radiotherapy for nasopharyngeal cancer: A case report 146
Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: Single-institution experience 145
Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Guided Radiotherapy 145
The impact of radiomics in diagnosis and staging of pancreatic cancer 145
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 144
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 143
New standards for the management of nose vestibule malignancies 140
[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches] 140
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy 138
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 138
Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients (Journal of Cancer Research and Clinical Oncology, (2021), 147, 3, (661-667), 10.1007/s00432-020-03411-7) 135
A deep learning approach to generate synthetic CT in low field MR-guided radiotherapy for lung cases 134
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 134
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 133
EROS study: Evaluation between high-dose-rate and low-dose-rate vaginal interventional radiotherapy (brachytherapy) in terms of overall survival and rate of stenosis 133
Automatic segmentation software in locally advanced rectal cancer: READY (REsearch program in Auto Delineation sYstem)-RECTAL 02: prospective study 132
Locally Advanced Prostate Cancer: Three-Dimensional Magnetic Resonance Spectroscopy to Monitor Prostate Response to Therapy 131
A new frontier of image guidance: Organs at risk avoidance with MRI-guided respiratory-gated intensity modulated radiotherapy: Technical note and report of a case 131
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 129
Modern Management of Esophageal Cancer: Radio-Oncology in Neoadjuvancy, Adjuvancy and Palliation 129
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 128
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 126
Intraluminal Brachytherapy in Unresectable Extrahepatic Biliary Duct Cancer: An Italian Pooled Analysis 124
Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches 123
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy. 123
Can automation in radiotherapy reduce costs? 122
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer 120
Perioperative HDR brachytherapy for reirradiation in head and neck recurrences: Single-institution experience and systematic review 119
May we routinely spare hippocampal region in primary central nervous system lymphoma during whole brain radiotherapy? 118
Role of chemoradiation (CRT) in the adjuvant treatment of radically resected pancreatic cancer (PC) patients (pts): a mono-institutional retrospective analysis 117
Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer 116
Hybrid Tri-Co-60 MRI radiotherapy for locally advanced rectal cancer: An in silico evaluation 116
Use of Indirect Target Gating in Magnetic Resonance-guided Liver Stereotactic Body Radiotherapy: Case Report of an Oligometastatic Patient 116
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 116
Radiation therapy for prostate cancer: What's the best in 2021 115
MITHRA - Multiparametric MR/CT image adapted brachytherapy (MR/CT-IABT) in anal canal cancer: A feasibility study 114
Individually optimized stereotactic radiotherapy for pancreatic head tumors: A planning feasibility study 113
Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients 113
Magnetic resonance guided SBRT reirradiation in locally recurrent prostate cancer: a multicentric retrospective analysis 109
Hypofractionated stereotactic radiotherapy for oligometastatic patients: developing of a response predictive model 109
Beyond geometrical overlap: a Dosimetrical Evaluation of automated volumes Adaptation (DEA) in head and neck replanning 108
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 108
Role of Chemoradiation in the Adjuvant Treatment of Radically Resected Pancreatic Cancer Patients: A Mono-Institutional Retrospective Analysis 107
Prevalence of HPV Infection and p16INK4a Overexpression in Surgically Treated Laryngeal Squamous Cell Carcinoma 107
Online adaptive magnetic resonance guided radiotherapy for pancreatic cancer: state of the art, pearls and pitfalls 107
Intra-operative radiotherapy (IORT) in pancreatic cancer: Joint analysis of the ISIORT-Europe experience. 106
Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival 106
Basics and frontiers on pancreatic cancer for radiation oncology: Target delineation, SBRT, SIB technique, MRgRT, particle therapy, immunotherapy and clinical guidelines 106
Case Report: A Case Report of Stereotactic Ventricular Arrhythmia Radioablation (STAR) on Large Cardiac Target Volume by Highly Personalized Inter- and Intra-fractional Image Guidance 104
MRI-guided stereotactic radiation therapy for hepatocellular carcinoma: a feasible and safe innovative treatment approach 104
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 103
Totale 14.967
Categoria #
all - tutte 70.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.193


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021200 0 0 0 0 0 0 0 0 0 52 133 15
2021/20221.261 121 65 16 127 57 41 21 198 55 102 212 246
2022/20232.796 371 389 220 464 161 336 139 240 323 31 92 30
2023/20241.259 45 340 41 161 46 192 55 89 11 38 123 118
2024/20252.533 58 87 176 95 270 83 77 130 394 268 508 387
2025/20265.878 952 175 313 670 1.149 313 1.132 335 457 382 0 0
Totale 18.225